Creation of a production unit for hyaluronic acid-based medical devices (Q2910604): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in pt, en, fr, de, nl, it, es, et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, and other parts: Adding translations: et, lt, it, fr, hr, el, en, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,) |
(Added qualifier: readability score (P590521): 0.000011549073841409742) |
||||||||||||||
| (7 intermediate revisions by 2 users not shown) | |||||||||||||||
| label / pt | label / pt | ||||||||||||||
Criação de uma unidade produtiva de dispositivos médicos à base de ácido hialurónico | |||||||||||||||
| label / en | label / en | ||||||||||||||
Creation of a production unit for hyaluronic acid-based medical devices | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
| Property / beneficiary name (string): BOHUS BIOTECH PORTUGAL LDA / rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: Q2986521 / rank | |||||||||||||||
| Property / budget | |||||||||||||||
| |||||||||||||||
| Property / budget: 5,569,777.0 Euro / rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 3,341,866.0 Euro / rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
| |||||||||||||||
| Property / co-financing rate: 60.0 percent / rank | |||||||||||||||
| Property / summary: None (English) / qualifier | |||||||||||||||
readability score: 0.000011549073841409742
| |||||||||||||||
| Property / contained in Local Administrative Unit | |||||||||||||||
| Property / contained in Local Administrative Unit: Sousel / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / priority axis | |||||||||||||||
| Property / priority axis: Enhancing the competitiveness of SMEs and reducing context-based public costs (TO 3 and TO2) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / thematic objective | |||||||||||||||
| Property / thematic objective: Competitiveness of SMEs / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
4,421,548.0 Euro
| |||||||||||||||
| Property / budget: 4,421,548.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
2,652,929.0 Euro
| |||||||||||||||
| Property / EU contribution: 2,652,929.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
60.0 percent
| |||||||||||||||
| Property / co-financing rate: 60.0 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: RAYNER BIOMATERIALS, UNIPESSOAL LDA / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
RAYNER BIOMATERIALS, UNIPESSOAL LDA | |||||||||||||||
| Property / beneficiary name (string): RAYNER BIOMATERIALS, UNIPESSOAL LDA / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / date of last update | |||||||||||||||
14 November 2023
| |||||||||||||||
| Property / date of last update: 14 November 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 10:32, 22 March 2024
Project Q2910604 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Creation of a production unit for hyaluronic acid-based medical devices |
Project Q2910604 in Portugal |
Statements
2,652,929.0 Euro
0 references
4,421,548.0 Euro
0 references
60.0 percent
0 references
1 January 2017
0 references
31 March 2019
0 references
RAYNER BIOMATERIALS, UNIPESSOAL LDA
0 references
38°57'8.06"N, 7°40'33.71"W
0 references
Sousel
0 references
14 November 2023
0 references
Identifiers
POCI-02-0853-FEDER-018929
0 references